RxDoctor Payments Data

Jacques Benun

Pediatrics · Austin, TXNPI 1952355471

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,543 of the $3,581 with a category attached, or 71.0%. 5 manufacturers reported payments, led by Astrazeneca UK Limited at 51.6% of the total. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,581in general payments, 2019–2025

Across 34 payments — averaging $105.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$2K
  • Eli Lilly$2K
  • Corcept Therapeutics$81
  • Novo Nordisk$24
  • Abbott$13
$1,336,687in research payments, 2019–2025

Across 248 payments — averaging $5389.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$457K
  • GSK$373K
  • Sanofi Pasteur Inc.$189K
  • Eli Lilly$184K
  • AstraZeneca$118K
  • Sanofi US Services Inc.$12K
  • plus $2K from 1 others

What the payments were for

  • Travel & lodging$2,54371%
  • Food & beverage$1,03829%

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited10$1,849
Eli Lilly21$1,614
Corcept Therapeutics1$81
Novo Nordisk1$24
Abbott1$13

How this compares

$3,581 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.

See all pediatrics providers in Texas →

Other pediatrics in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →